Current directions in tau research: Highlights from Tau 2020 - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring Année : 2021

Current directions in tau research: Highlights from Tau 2020

1 Alzheimer's Association
2 Asceneuron [Lausanne, Switzerland]
3 UC San Francisco - University of California [San Francisco]
4 ADDI - Alzheimer's Disease Data Initiative [Kirkland, WI, USA]
5 ULB - Université libre de Bruxelles
6 LilNCog - Lille Neurosciences & Cognition - U 1172
7 NPB - Neuroscience and Platform Biology [Arvinas, NH, USA]
8 PhIND - Physiopathologie et imagerie des troubles neurologiques
9 BB@C - Institut Blood and Brain @ Caen-Normandie [Caen]
10 Cyceron - GIP Cyceron
11 UCB-B - UCB Biopharma [Brussels, Belgium]
12 DT - Denali Therapeutics [San Francisco, CA, USA].
13 C-PSP - Cure PSP [New York, NY, USA]
14 UC San Diego - University of California [San Diego]
15 University of Texas Health Science Center at San Antonio [San Antonio, Tx, USA]
16 MSSM - Icahn School of Medicine at Mount Sinai [New York]
17 Abbvie Inc. [North Chicago]
18 HMS - Harvard Medical School [Boston]
19 Massachusetts General Hospital - Department of radiology
20 WUSTL - Washington University in Saint Louis
21 University of Texas Southwestern Medical Center [Dallas]
22 NINDS - National Institute of Neurological Disorders and Stroke [Bethesda]
23 UCL Institute of Neurology, Queen Square [London]
24 UCL - University College of London [London]
25 LF - Longwood Fund [Boston, MA, USA]
26 Mayo Clinic [Rochester]
27 RCF - Rainwater Charitable Foundation [Fort Worth, TX, USA]
28 Biogen [Boston, MA, USA]
29 FBRI - F-Prime Capital [Cambridge, MA, USA]
30 Genentech, Inc. [San Francisco]
31 ISW - Independent science writer [Bryn Mawr, PA, USA]
Claire Sexton
Luc Buée
Celeste Karch

Résumé

Studies supporting a strong association between tau deposition and neuronal loss, neurodegeneration, and cognitive decline have heightened the allure of tau and tau-related mechanisms as therapeutic targets. In February 2020, leading tau experts from around the world convened for the first-ever Tau2020 Global Conference in Washington, DC, co-organized and cosponsored by the Rainwater Charitable Foundation, the Alzheimer's Association, and CurePSP. Representing academia, industry, government, and the philanthropic sector, presenters and attendees discussed recent advances and current directions in tau research. The meeting provided a unique opportunity to move tau research forward by fostering global partnerships among academia, industry, and other stakeholders and by providing support for new drug discovery programs, groundbreaking research, and emerging tau researchers. The meeting also provided an opportunity for experts to present critical research-advancing tools and insights that are now rapidly accelerating the pace of tau research.
Fichier principal
Vignette du fichier
alz.12452.pdf (392.45 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03357428 , version 1 (28-09-2021)

Identifiants

Citer

Claire Sexton, Heather Snyder, Dirk Beher, Adam Boxer, Pat Brannelly, et al.. Current directions in tau research: Highlights from Tau 2020. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, Online ahead of print. ⟨10.1002/alz.12452⟩. ⟨inserm-03357428⟩
42 Consultations
126 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More